Mer expression in tumor cells (MERt) was detected (H-score ≥ 5) in 67% of patients (Table 1) and was generally low-to-moderate with a median H-score of 10 (range: 0–300) while intermediate (H-score = 101–200) and high (H-score = 201–300) Mer expression was seen in 11% and 2% of patients respectively. This evidence concerns the gene MERTK and neoplasm.